Position in JNJ
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,210,808
+$97,380 QoQ
Shares Held
8,705
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
#2,267
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 53%
Shared 0%
None 47%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alhambra Investment Management LLC holds $9,363,953 across 10 Drug Manufacturers - General names. JNJ ranks #1 (23.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
8,705 | $2,210,808 | |
| 2 | AMGN |
Amgen Inc
|
4,329 | $1,567,617 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,112 | $1,299,392 | |
| 4 | LLY |
ELI LILLY & Co
|
1,067 | $1,279,791 | |
| 5 | NVS |
Novartis AG
|
5,321 | $833,907 | |
| 6 | ABBV |
AbbVie Inc.
|
2,924 | $735,795 | |
| 7 | AZN |
Astrazeneca PLC
|
2,840 | $538,520 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,185 | $413,999 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,210,808 | 8,705 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,113,428 | 8,646 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,811,019 | 8,751 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $1,622,610 | 8,751 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $1,393,538 | 9,123 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,509,144 | 9,100 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $1,314,161 | 9,087 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,453,192 | 8,967 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,310,616 | 8,967 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,458,195 | 9,218 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,490,283 | 9,508 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,471,993 | 9,451 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $1,628,054 | 9,836 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,533,570 | 9,894 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,747,068 | 9,890 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $1,619,551 | 9,914 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,768,354 | 9,962 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $1,803,138 | 10,174 | Shares | Sole | 2022-04-19 | |
| 2021-12-31 | $1,715,489 | 10,028 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,643,424 | 10,176 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,676,394 | 10,176 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,611,616 | 9,806 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $1,453,561 | 9,236 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,378,033 | 9,256 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $1,269,467 | 9,027 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $939,153 | 7,162 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||